PHILADELPHIA (April 22, 2021)—The use of molecular profiling to identify the molecular and genetic signatures of cancer and deliver highly specific treatments was named the top advance of the year in the treatment of cancer, according to a recent collaborative report from the American Society of Clinical Oncology (ASCO).

PHILADELPHIA (April 21, 2021)—Researchers at Fox Chase Cancer have published a study investigating the safety and efficacy of a vaccine, given alone and in combination with a PD-1 checkpoint inhibitor, that may prevent colon cancer in certain populations. In a preclinical in vivo model, when administered to mice predisposed to develop colon cancer, the vaccine primed their immune systems to recognize and fight cancer cells and prevent tumors from forming.

PHILADELPHIA (April 16, 2021)—Alexander Kutikov, MD, FACS, chief of the Division of Urology and Urologic Oncology at Fox Chase Cancer Center, co-authored two publications examining important treatment decisions in kidney cancer and illustrating the role of minimally invasive partial nephrectomy—partial removal of the kidney—in the treatment of renal masses, which are abnormal growths on the kidney.